Skip to content

    Recently Viewed


      Home / Latest news / Innovation /
      The monster and the scientists

      The monster and the scientists

      Share Article
      share to

      As he looks at a three dimensional computer model of a molecule that has consumed him for months, Hans describes the virus with great respect as a monster, the monster:

      “This little monster is responsible for the infection, and this structure shows us how it can infect and how it can multiply. We’re talking about diseases that can just travel. It’s gets in your body, and it easily attaches itself to you.”

      Hanneke has been obsessed with how viruses work since she was in college.

      “I thought, this is something that needs to be solved. We need to understand, how can a virus make people so ill? I was fascinated.”

      Maria, Benoit; they are leaders of global teams having great impact on HIV, Ebola, TB, and a virus called RSV that is one of the most common killers of young children.

      Hans Langedijk.
      Hanneke Schuitemaker.
      Maria Grazia Pau.
      Benoit Callendret.

      They change the perception of what you expect to see of a scientist. They are all scientists at Johnson & Johnson, yet none of these people work in a lab. Their tools are computer models and data. They begin after the lab work is completed, embracing the discovery or the breakthrough and charging forward to make that discovery a real vaccine that can save a life.

      Success here is proving it works and getting it into the world on a scale that changes the course of history, that saves communities and families.

      Yet they don’t think of their work in that way. They don’t put faces on the disease, even though when in conversation the human impact is clearly understood.

      It’s as if thinking of the child living or dying based on their success or failure is too much to process. It wouldn’t allow them to focus on the work.

      And so the work is done, and progress is made, one click, one conference call, one advance, one clinical trial, one moment of perseverance or luck. Anything that gets them, and us, closer to the goal.

      More from Johnson & Johnson

      Health & wellness
       Intense and extreme heat wave under the sun illustrating the impact of climate change

      Building climate-resilient health clinics

      When Mother Nature strikes—think triple-digit heatwaves, wildfires, hurricanes—vulnerable populations are at risk of missing out on much-needed healthcare. For Earth Day, learn how Johnson & Johnson is helping community clinics protect patients.
      Latest news
      Q1 2024-1x1.png

      What you need to know about Johnson & Johnson’s 2024 first-quarter earnings

      Here’s an infographic breakdown of the company’s first-quarter earnings results, including key highlights from its Innovative Medicine and MedTech businesses.
      Latest news
      healthcare worker in protective medical gear

      Johnson & Johnson named to Fortune’s 2024 America’s Most Innovative Companies list

      The company’s drive to develop novel solutions for the world’s toughest healthcare challenges has earned it a spot on Fortune’s second annual list.
      You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.